| Business Summary | | AmeriPath,
Inc.
is
a
physician
and
laboratory
company
focused
on
providing
anatomic
pathology,
cancer
diagnostic,
genomics
and
healthcare
information
services.
Since
its
inception,
the
Company
has
completed
the
acquisition
of
49
physician
practices
(the
Practices)
located
in
21
states.
These
Practices
are
either
directly
owned
by
the
Company,
or
managed
by
the
Company
through
one
of
its
subsidiaries.
The
Company
essentially
operates
as
a
pathology
group
practice.
The
Company's
425
pathologists
provide
medical
diagnostic
services
in
outpatient
laboratories
owned,
operated
and
managed
by
the
Company,
hospitals
and
outpatient
ambulatory
surgery
centers.
Of
these
pathologists,
419
are
board
certified
in
anatomic
and
clinical
pathology,
and
190
are
also
board
certified
in
a
subspecialty
of
anatomic
pathology,
including
dermatopathology
(study
of
diseases
of
the
skin),
hematopathology
(study
of
diseases
of
the
blood)
and
cytopathology
(study
of
abnormalities
of
the
cells). | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | AmeriPath,
Inc.
is
an
integrated
physician
group
practice
and
laboratory
management
company
providing
anatomic
pathology
diagnostic
services.
For
the
six
months
ended
6/30/01,
revenue
increased
31%
to
$203.8
million.
Net
income
applicable
to
Common
increased
66%
to
$12.4
million.
Revenues
reflect
higher
outpatient
revenues
and
acquisitions.
Earnings
also
benefitted
from
improved
gross
and
operating
margins. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| James New, 55 Chairman,
CEO | $600K | Brian Carr, 39 Pres,
Director | -- | Gregory Marsh, 40 CFO,
VP, Sec. | -- | Alan Levin, M.D., 49 COO | 376K | Dennis Smith, Jr., M.D., 49 Exec.
VP, Genomic Strategies and CMO | 252K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|